Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Photobiomodulation effects on cognitive function - a systematic review and meta-analysis of randomized controlled trials

Registration number: CRD42024552832. Registration data: 2024/06/10.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors pooled 24 randomized trials involving 820 participants to examine photobiomodulation and cognitive function. They report significant pooled benefits versus control for global cognitive function, working memory span, attention and executive function reaction time, with the authors urging caution due to heterogeneity and study limitations.

Participants
820
Studies included
24
Who or what was studied
Healthy adults and subjects with cognitive impairment
Limits stated in the abstract
The authors state that the findings should be treated with caution due to heterogeneity and limitations of the included studies.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Systematic review, Meta-analysis, Control group, Heterogeneity, Risk of bias, Sham. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial

Cognitive, metabolic, and network-level findings are consistent with enhanced mitochondrial efficiency and anti-inflammatory effects. These results support larger, double-blind, multicenter trials to evaluate tPBM as a mitochondria-targeted therapy in early ADRD.

Trial · June 3, 2026 · Rashidi-Ranjbar N et al.